Anavex Life Sciences Corp (AVXL)

[kevindenver]

Very exciting stuff on the Rett front, how it's all filed with the FDA is still up for debate. We've learned how trial parameters are definitely important, as shown in the measurement debates with RQBQ-AUC versus change from baseline.

On the rare disease front in general, trials should be starting soon. Oh and the "mystery indication"...